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ABSTRACT 46 
Background 47 
Optimum sedation of intensive care (ICU) patients requires the avoidance of pain, agitation, 48 
and unnecessary deep sedation, but achieving this is challenging. Excessive sedation can 49 
prolong ICU stay whereas light sedation may increase pain and frightening memories, which 50 
are commonly recalled by ICU survivors. We evaluated the effectiveness of three 51 
interventions that may improve sedation-analgesia quality: an online education programme; 52 
regular feedback of sedation-analgesia quality data; and use of a novel sedation-monitoring 53 
technology (Responsiveness Index, RI).  54 
Methods 55 
We did a cluster randomised trial in eight ICUs. These were randomly allocated to receive: 56 
education alone (two ICUs); education plus sedation-analgesia quality feedback (two ICUs); 57 
education plus RI monitoring technology (two ICUs); or all three interventions (two ICUs). A 58 
45 week baseline period was followed by a 45 week intervention period, separated by an 59 
eight week implementation period in which the interventions were introduced. All 60 
mechanically ventilated patients were potentially eligible. We assessed patients’ sedation-61 
analgesia quality for each 12-hour nursing care period, and sedation-related adverse events 62 
(SRAEs) daily. Our primary outcome was the proportion of care periods with optimum 63 
sedation-analgesia, defined as free from excessive sedation, agitation, poor limb relaxation 64 
and poor ventilator synchronisation. Analysis used multilevel generalised linear mixed 65 
modelling to explore intervention effects in a single model taking clustering and patient 66 
level factors into account.  67 
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The trial is registered as Clinicaltrials.gov NCT01634451. 68 
Findings  69 
Between 1st June 2012 and 31st December 2014, we included 881 patients (9187 care 70 
periods) during the baseline period and 591 patients (6947 care periods) during the 71 
intervention period. During the baseline period optimum sedation-analgesia was present for 72 
56·1% of care periods. We found a significant improvement in optimum sedation-analgesia 73 
with RI monitoring (OR 1·44 (95% CI: 1·07-1·95; p=0·017)) which was mainly due to 74 
increased periods free from excessive sedation (OR 1·59 (1·09-2·31)) and poor ventilator 75 
synchronisation (OR 1·55 (1·05-2·31)). However, more patients experienced SRAEs (RR 1·91 76 
(1·02-3·58)). We found no improvement in overall optimum sedation-analgesia with 77 
education, but fewer patients experienced SRAEs (RR 0·56 (0·32-0·99)). The sedation-78 
analgesia quality data feedback did not improve quality or safety. The statistical modelling 79 
predicted that for an average ICU patient a combination of responsiveness monitoring and 80 
online education increased the proportion of care periods with optimum sedation-analgesia 81 
by about 10% (from 61·6% to 72·3%) without increasing SRAEs. 82 
Interpretation 83 
Combining RI monitoring and online education has potential to improve sedation-analgesia 84 
quality and patient safety in mechanically ventilated ICU patients. 85 
Funding 86 
Chief Scientists Office, Scotland; GE Healthcare (Unrestricted funding).  87 
  88 
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INTRODUCTION 89 
Deep sedation during mechanical ventilation in the intensive care unit (ICU) is associated 90 
with longer ICU stay, more infections, and higher mortality.1 Strategies promoting lighter 91 
sedation can improve these outcomes but increase the risk of patient agitation and 92 
discomfort. Pain and frightening memories are widely reported by ICU survivors, and are 93 
associated with longer-term psychological problems, especially post-traumatic stress.2-4  94 
Guidelines recommend simultaneous avoidance of deep sedation, pain, and agitation, but 95 
changing staff behaviour to improve management is challenging.3,5 Most previous trials have 96 
used protocols or daily sedation breaks, but the effectiveness of these interventions is 97 
uncertain and probably context specific.6,7  98 
Sedation-analgesia management is a priority for improving ICU patient care.8-10 Potential 99 
quality improvement strategies include staff education, regular feedback of sedation-100 
analgesia quality data, and bedside sedation-monitoring technologies. Inadequate staff 101 
education is a known barrier to sedation-analgesia improvement,11 12 and staff anxiety and 102 
increased workload from greater patient wakefulness may limit behaviour change.5,13,14 103 
Regular feedback of quality data has been successful in decreasing ICU-acquired infections, 104 
especially using process control methodology to track change over time.15,16 However, the 105 
effectiveness of this approach has not been evaluated for improving sedation-analgesia 106 
quality. Although several bedside sedation-monitoring technologies exist, these have not 107 
previously been evaluated in large ICU effectiveness trials. Existing technologies were 108 
primarily developed to monitor depth of anaesthesia, their discriminant ability in the target 109 
sedation states during ICU care is limited, and they are only recommended in specific 110 
situations such as during neuromuscular paralysis. 3,17  111 
We developed three contrasting interventions that might improve sedation-analgesia 112 
quality in mechanically ventilated critically ill patients. First, an online evidence-based 113 
education resource; second, process feedback charts for tracking and regular feedback of 114 
sedation-analgesia quality; and third, a novel bedside technology designed to continuously 115 
monitor patients for possible deep sedation (Responsiveness Index (RI)).18-22 We report a 116 
cluster randomised trial to evaluate the effectiveness of each of these interventions for 117 
improving sedation-analgesia quality in mechanically ventilated critically ill patients.  118 
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METHODS 119 
The trial was part of a research programme funded by the Chief Scientist’s Office Scotland 120 
(CZH/3/3) and with unrestricted support from GE Healthcare (Development and Evaluation 121 
of Strategies to Improve Sedation practice in inTensive care; DESIST, ClinicalTrials.gov 122 
NCT01634451) 123 
Design  124 
We did a cluster randomised trial in eight Scottish ICUs that admit mixed medical-surgical 125 
critically ill patients, excluding specialist cardiac, neurosurgical, or paediatric patients. We 126 
collected sedation-analgesia quality and other outcome data in all ICUs for 45 weeks 127 
(baseline period). We then randomly allocated ICUs to implement up to three interventions 128 
over an eight week period: online education (“education”); sedation-analgesia quality 129 
feedback (“process feedback”); and sedation monitoring technology (“responsiveness 130 
monitoring”). There were four pre-defined intervention combinations: education alone (two 131 
ICUs); education plus process feedback (two ICUs); education plus responsiveness 132 
monitoring (two ICUs); or all three interventions (two ICUs). Data were then collected for a 133 
further 45 weeks (intervention period). In a single analytic model we used a before-after 134 
approach (baseline versus intervention) to assess the effectiveness of education, and a 135 
parallel group factorial analysis to assess the effectiveness of process feedback and 136 
responsiveness monitoring, adjusting for potential confounders and outcomes observed in 137 
the baseline period. We evaluated effectiveness in clusters (ICUs) by analysing outcomes 138 
both at the care period level (12-hour nursing shift) and summarised at patient level. A 139 
process evaluation was included to further assess the impact of each intervention and to 140 
better understand the results. A detailed description of the study design, methodology, and 141 
analysis plan have been previously published.23  142 
Setting and Participants 143 
We selected ICUs in Scotland from teaching (N=4) and district general hospitals (N=4) that 144 
admitted between 202 and 798 mechanically ventilated patients annually (see 145 
http://www.sicsag.scot.nhs.uk). We selected ICUs to represent a typical UK case-mix. Nurse-146 
patient ratio was 1:1 for mechanically ventilated patients consistent with UK national 147 
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guidance, and pre-trial approaches to sedation-analgesia management in each ICU are 148 
described in the supplement (table S1). We aimed to study patients requiring at least 24-48 149 
hours of mechanical ventilation. Although interventions were at the ICU level the Adults 150 
with Incapacity (Scotland) Act 2000 required us to obtain consent from a relative/welfare 151 
guardian to collect data and include patients in the analysis. All mechanically ventilated, 152 
intubated patients were potentially eligible if consent was obtained within 48 hours of 153 
starting mechanical ventilation. Exclusion criteria were patients: no longer mechanically 154 
ventilated when screened or expected to be extubated within 4 hours; where active therapy 155 
was being withdrawn; and where the responsible clinician declined permission. Detailed 156 
screening logs captured enrolment rates and reasons for non-inclusion throughout the trial. 157 
The study was approved by the Scotland A Research Ethics committee (11/SS/0065).   158 
Trial Interventions  159 
Education: We delivered a nine module education package through the National Health 160 
Service provider of web-based educational materials (LearnPro NHS: 161 
http://www.learnpro.co.uk). Modules covered topics relating to sedation, analgesia, 162 
agitation, sleep, and delirium management in the ICU and included inbuilt assessments. 163 
Nurses completed training during the eight week implementation period, but the education 164 
package was available throughout the intervention period; it can be viewed at 165 
http://packagemanager.learnprouk.com (username “desisttest”; password “welcome”). 166 
Process feedback:  We developed statistical process control charts that described rates 167 
of overall optimum sedation, agitation, excessive sedation, poor relaxation, poor ventilator 168 
synchronisation, and patients experiencing sedation-related adverse events (SRAEs) at 169 
sequential two month intervals.16,18 The methodology for this has been previously 170 
published.18 We provided sedation-analgesia quality reports to ICUs randomised to this 171 
intervention during the eight week implementation period, and then updated reports every 172 
two months during the intervention period using ongoing trial data. ICUs were provided 173 
with strategies to share data from the reports (including posters and slide-sets) and 174 
encouraged to integrate these into quality improvement and other activities. An example of 175 
a report is included in supplementary material. 176 
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Responsiveness monitoring: We introduced a novel technology, Responsiveness Index (RI), 177 
into practice during the implementation period in the ICUs randomised to this intervention. 178 
RI is a continuous measure of patient arousal based on facial electromyography (fEMG) 179 
collected via frontal electrodes. The RI was colour-coded to indicate low arousal (red 180 
colour), intermediate arousal (amber colour), and higher arousal (green colour). The 181 
algorithm,20 clinical validation studies,21,22 and a proof of concept trial19 have been 182 
published previously. Low arousal occurs during deep sedation, but also during natural 183 
sleep, low levels of clinical stimulation, and as a result of illness related coma. In the trial RI 184 
monitoring was intended to support bedside decision-making by clinical staff. Continuous RI 185 
monitoring was encouraged for all enrolled sedated patients. We asked nurses to use red RI 186 
values as a trigger to review sedation, reduce sedative doses, and transition patients into 187 
the amber/green RI range.  188 
Outcomes 189 
Our primary outcome was the proportion of care periods with optimum sedation-analgesia. 190 
We defined a care period as a 12 hours nursing shift and assessed sedation-analgesia with a 191 
quality assessment tool (SQAT) developed and validated prior to the trial.18 The SQAT was 192 
implemented into routine daily practice in all ICUs prior to the baseline period and 193 
completed by staff at the end of each care period throughout the trial. We defined optimum 194 
sedation-analgesia as a care period free from excessive sedation, agitation, poor ventilator 195 
synchronisation, and poor relaxation. Care periods with each of the four quality components 196 
were reported as secondary outcomes.  197 
Secondary patient level outcomes were the numbers of care periods within each patient 198 
with overall optimum sedation-analgesia and with each quality component. 199 
Additional data were collected by research staff. Safety outcomes were the proportion of 200 
days during mechanical ventilation on which a SRAE occurred (defined as unplanned 201 
removal of nasogastric tube, central line, arterial line or drain; unplanned extubation; staff 202 
injury; or patient injury) and the proportion of patients who experienced SRAEs. Secondary 203 
outcomes were sedative and analgesic drug use (expressed as propofol and alfentanil 204 
equivalents), the proportion of days on which high dose (≥4000mg) propofol was 205 
administered (as a secondary safety outcome for risk of propofol-infusion syndrome), and 206 
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the proportion of patients receiving haloperidol (the first-line antipsychotic used for 207 
delirium management). Duration of mechanical ventilation, ICU and hospital stay, and ICU 208 
and hospital mortality were also recorded.  209 
Sample Size  210 
We did not know the rates of optimum sedation-analgesia and intraclass correlation 211 
coefficients (ICC) when designing the trial. We therefore modelled sample size to detect a 212 
25% increase in the proportion of care periods with optimum sedation-analgesia with each 213 
trial intervention (power 80%; 2-sided significance level 5%) assuming a 70% optimum 214 
sedation-analgesia rate during baseline.  We estimated sample size using a range of ICC 215 
(0.04 to 0.13) and patient numbers enrolled per ICU in each period (66 to 250). We re-216 
checked power during the baseline period based on recruitment rates in participating ICUs. 217 
Our target sample size was 1600 patients (100 per ICU in both baseline and intervention 218 
periods). We estimated this would require 98 weeks per ICU (45 weeks baseline; 8 weeks 219 
implementation; 45 weeks intervention).   220 
Randomisation and allocation concealment  221 
ICUs started the study in a staggered manner to enable research team support during 222 
implementation. Randomised allocation was revealed to ICUs at the end of the baseline 223 
period to ensure allocation concealment. Randomisation used computer-generated random 224 
permuted blocks, stratified according to recruitment start date (“early”: first four ICUs; 225 
“late”: last four ICUs), to help balance numbers recruited across randomised groups. 226 
Blinding 227 
ICU and research staff were unaware of the intervention allocation during baseline data 228 
collection. As the trial aimed to modify behaviour we could not blind clinicians during the 229 
intervention phase. Clinical and research staff collected raw trial data every day as part of 230 
routine practice, but analysis to generate all trial outcome measures was done remotely by 231 
a statistician concealed from group allocation. Patients lacked mental capacity during the 232 
intervention and were unaware of ICU allocation. 233 
Analysis 234 
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A detailed trial analysis plan was agreed prior to database lock.23 We evaluated the effect of 235 
each intervention using multilevel generalised linear mixed models to account for the 236 
nested structure of the data, namely: care period (level one), within admission (level two), 237 
within ICU (level three). We planned to fit a three-level multilevel model, but if the nature of 238 
the data meant this was not feasible an alternative two-level multilevel model with care period 239 
(level one) and admission (level two) was pre-specified. We used Markov Chain Monte Carlo 240 
methods for parameter estimation and reported ICCs at admission and ICU levels. 241 
We pre-defined a two-stage approach to analysis. First, an odds ratio (with 95% confidence 242 
interval (CI)) was calculated for the baseline to intervention change within each ICU, 243 
recognising that intervention uptake might vary between ICUs. At a pre-planned meeting, 244 
these data were reviewed by the independent data monitoring committee (IDMC) together 245 
with a report of qualitative process evaluation data that summarised uptake and 246 
engagement with interventions (prepared by a researcher (KK) blinded to quantitative data). 247 
The IDMC decided whether effects observed within individual ICUs supported proceeding to 248 
the pre-defined main analysis, which was a pooled analysis summarising overall intervention 249 
effects in the study. 250 
Our primary analysis was a multilevel logistic regression. Fixed effect independent variables 251 
at the ICU level were: time period (baseline or intervention), interventions (process 252 
feedback and responsiveness monitoring), and intervention by time period interaction. 253 
Fixed effect independent variables at admission level were: age, sex, and APACHE II score (a 254 
measure of illness severity). We tested for an interaction between the process feedback and 255 
responsiveness monitoring interventions. Intervention effects were presented as odds ratios 256 
(95% CI). We did a pre-planned sensitivity analysis using intervention data recorded in the 257 
final 30 weeks of the study to check for sustained effects 4-5 months post-implementation. 258 
A detailed description of the analytic approach and the models used for the secondary 259 
outcomes have been published previously.23  260 
Analyses used STATA (StataCorp; www.stata.com), MLwiN (University of Bristol; 261 
www.bristol.ac.uk/cmm/software/mlwin) and SAS (www.sas.com) statistical software.  262 
In order to provide an illustration of the clinical impact of the interventions, we used mean 263 
age, sex and APACHE II score from the baseline period and the average treatment effects 264 
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from education, education plus process feedback, and education plus responsiveness 265 
monitoring observed in the trial to estimate the changes in sedation-analgesia quality and 266 
safety for an average ICU patient. 267 
Process evaluation 268 
For education we recorded the proportion of nursing staff completing online training in 269 
each ICU. To assess changes in knowledge, nurses answered ten core knowledge questions 270 
prior to starting education and repeated this at least five months after the implementation 271 
phase. Mean change in core knowledge test score was measured using analysis of 272 
covariance, adjusting for the pre-intervention score. For sedation-analgesia quality feedback 273 
we recorded the number of reports provided to ICUs during the intervention period. For 274 
responsiveness monitoring we recorded the number of patients monitored, duration of 275 
monitoring, and patterns of hourly RI data recorded by nursing staff.  276 
An inductive thematic analysis of focus group data and field work undertaken in all ICUs 277 
throughout the study was undertaken by an ethnographic researcher (KK) and checked by 278 
an independent qualitative researcher (JH) according to a pre-specified plan. These data 279 
enabled detailed understanding of variation in the fidelity and reach of the intervention and 280 
staff perceptions across the ICUs. A description of the process evaluation design has been 281 
previously published and further details provided in supplementary material.23    282 
Role of the funding source 283 
The funders of the study had no role in study design, data collection, data analysis, data 284 
interpretation, or writing of the report. The corresponding author had full access to all the 285 
data in the study and had final responsibility for the decision to submit. 286 
 287 
RESULTS 288 
Between 1st June 2012 and 31st December 2014, 881 patients were included during the 289 
baseline period and 591 patients during the intervention period. A summary of recruitment, 290 
patient demographics, and numbers of care periods with primary outcome data available 291 
for each ICU is shown in figure 1. Data describing admission diagnostic categories, and 292 
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additional detail concerning screening/enrolment are provided in supplementary material 293 
(table S2 and S3).  294 
Our analysis of changes in sedation-analgesia quality in individual ICUs suggested variation 295 
in effects, with significant and potentially important changes between the baseline and 296 
intervention periods occurring in some ICUs. These are illustrated in supplementary material 297 
(figure S1). Our qualitative data suggested that this might be partly explained by differences 298 
in engagement with interventions between ICUs, including ICUs randomised to the same 299 
interventions. At the IDMC review members unanimously recommended undertaking the 300 
pooled main analysis to estimate overall effects from each intervention. 301 
The baseline rates for overall optimum sedation-analgesia and for each of the sedation-302 
analgesia quality components are shown in table 1. This showed that 56.1% of care periods 303 
had optimum sedation-analgesia prior to the interventions with relatively high rates of care 304 
periods free from unnecessary deep sedation (80·6%), agitation (90·1%), poor relaxation 305 
(82·7%), and poor ventilator synchronisation (89·2%).  306 
Pooled raw data for the primary outcome prior to modelling indicating the number of 307 
patients and care periods available for analysis by phase and intervention are included in 308 
the supplementary material (table S4). These raw data suggested that there was no change 309 
(baseline to intervention) in rates of optimum sedation-analgesia associated with education 310 
or in the four ICUs that received process feedback, but an increase in optimum sedation-311 
analgesia of 7·0% occurred in the ICUs randomised to responsiveness monitoring. 312 
We found that ICU variance was small (ICC=0.003) suggesting a lack of clustering at ICU 313 
level, so we conducted multilevel modelling using a 2-level model. We also found no 314 
evidence for interaction between the process feedback and responsiveness monitoring 315 
interventions (p=0.08) so this interaction was excluded. The ICCs for all two-level analyses 316 
are shown in the supplementary material (table S5). 317 
Results from modelling the effects of the interventions on the primary outcome and its 318 
components are summarised in figure 2. There was no statistically significant effect from 319 
education on overall optimum sedation-analgesia (OR 1.13 (95% CI: 0.86-1.48); p=0.392), 320 
but both days (RR 0.52 (0.30-0.92)) and patients (RR 0.56 (0.32-0.99)) with SRAEs decreased. 321 
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Responsiveness monitoring resulted in a significant improvement in optimum sedation-322 
analgesia (OR 1.44 (1.07-1.95); p=0.017), which appeared to result from an increase in care 323 
periods free from excessive sedation (OR 1.59 (1.09-2.31)) and poor ventilator 324 
synchronisation (OR 1.55 (1.05-2.30)). Patient level analyses showed a similar pattern of 325 
findings (table 2A). In contrast, responsiveness monitoring appeared to increase patients 326 
experiencing SRAEs (RR 1.91 (1.02-3.58)). Process feedback demonstrated no beneficial 327 
effects on the optimum sedation-analgesia quality (OR 0.74 (0.54-1.00); p=0.052) or any 328 
secondary outcomes, and in the modelling there was a decrease in excessive sedation free 329 
care periods.  330 
Other secondary outcomes are shown in tables 2B and 2C. We found no differences in 331 
average drug use per patient or length of mechanical ventilation, ICU or hospital stay, or 332 
mortality.  333 
The effects we observed were similar in the sensitivity analysis restricted to data from the 334 
last 30 weeks of the intervention period (see table S6). 335 
The predictions from modelling the effects of intervention combinations for an average ICU 336 
patient enrolled in the trial are shown in table 3. The modelling predicted that the 337 
combination of education and responsiveness monitoring resulted in a 10-11% 338 
improvement in the proportion of care periods with optimum sedation from 61.6% to 339 
72.3%, mainly as a result of decreased deep sedation without an increase in SRAEs. 340 
  341 
Process evaluation 342 
Education: Most nurses completed the training during the implementation period (range 343 
74% to 100% across the ICUs). Nursing knowledge increased from a mean pre-education 344 
score of 6.4 (SD 1.8) out of 10 by an average of 0.82 (95% CI: 0.65-0.98) adjusted for pre-345 
education score (P<0.0001). The qualitative data suggested education was universally 346 
valued, considered comprehensive, and a useful resource especially for less experienced 347 
staff. Its impact appeared greatest on the awareness and management of agitation and 348 
delirium, and was perceived to increase nursing autonomy.  349 
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Process feedback: All four ICUs received the two-monthly sedation-analgesia quality reports 350 
as planned. However, qualitative data suggested process feedback was poorly understood 351 
and was sometimes disbelieved by staff especially when indicating poor sedation-analgesia 352 
quality. Process feedback had poor penetration within ICUs and was thought to lack 353 
relevance to daily bedside practice. 354 
Responsiveness monitoring: Most enrolled patients were monitored (82% of enrolled 355 
patients; range 76% to 95% between the four ICUs). Monitoring initiation was delayed in 356 
many patients (median (1st, 3rd quartile) time between intubation and monitoring 21 hours 357 
(11, 34)), most likely while consent was obtained. The first RI value was red in most patients 358 
(59% overall; range 50-66% across ICUs) and remained red for a median 35% of monitored 359 
time (range 23 to 48% across ICUs). The median time to first achieving a green RI value was 360 
9 hours (4, 23), suggesting nurses were not always acting on RI data or interventions to 361 
increase RI values were unsuccessful. The qualitative data suggested that many nurses 362 
found the technology a useful bedside prompt to review sedation management but views 363 
were mixed and some staff understood the monitor poorly, questioned its utility and 364 
validity, found its bedside presence intrusive, and did not alter their practice. 365 
A more detailed summary of the process evaluation is presented in the supplement.  366 
 367 
DISCUSSION 368 
We found that optimum sedation-analgesia, meaning a patient was free from deep 369 
sedation, agitation, poor relaxation and poor ventilator synchronisation, was improved after 370 
implementing responsiveness monitoring technology. This intervention decreased the 371 
proportion of care periods with deep sedation and poor ventilator synchronisation, but 372 
increased SRAEs. A web-based education intervention did not affect overall optimum 373 
sedation-analgesia quality, but decreased SRAEs. The regular feedback of sedation-analgesia 374 
quality data did not improve outcomes or safety. Using statistical modelling, we estimated 375 
that the implementation of the education and responsiveness monitoring combination 376 
increased the absolute proportion of time with optimum sedation-analgesia by about ten 377 
percentage points for an average ICU patient without increasing SRAEs. 378 
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The most effective intervention, the responsiveness technology, was a continuous objective 379 
bedside alert to the possibility of deep sedation. Responsiveness Index is not linearly related 380 
to clinical sedation scores which was why we used it to assist decision-making rather than 381 
link values to strict protocols.21 Sedation-analgesia quality improved mainly by decreasing 382 
deep sedation, consistent with the monitoring concept.19-21 Our process evaluation found 383 
that monitoring was not started for >20 hours in more than half of patients and that red 384 
values occurred for prolonged periods despite guidance to review and decrease sedation. 385 
There was variable reach and penetration of the technology within ICUs consistent with 386 
delays in technology adoption. It is possible that greater improvements to sedation-387 
analgesia quality with responsiveness monitoring might therefore be achieved with more 388 
education, experience and confidence in the technology and the use of decision-making 389 
protocols directly linked to RI data. The increase in SRAEs following introduction of 390 
responsiveness monitoring may have occurred because less time was spent with deep 391 
sedation. Concerns regarding agitation and adverse events are known to affect the 392 
willingness of nurses to decrease sedation.13,14 Our data suggest responsiveness monitoring 393 
successfully changed the behaviour of bedside staff, although further work is required to 394 
maximise its uptake and clinical effectiveness.   395 
The education intervention did not improve sedation-analgesia quality, but was associated 396 
with an almost 50% relative reduction in SRAE rates compared to baseline. This result was 397 
surprising, but is clinically important because adverse events may directly contribute to 398 
patient complications. Inadequate education and training are known barriers to sedation-399 
analgesia improvement, and are difficult to overcome given the high staff numbers and 400 
turnover in many ICUs.11,12 Specifically, increasing wakefulness through strategies such as 401 
daily sedation breaks is perceived to increase patient agitation, workload and nurse 402 
anxiety.5,13,14 The management of pain, agitation and delirium was a strong focus of the 403 
education intervention and the process evaluation indicated that these elements were most 404 
positively perceived by staff, resulting in improved knowledge which was retained over 405 
time. Although this part of the analysis used a before-after approach, and it is possible that 406 
temporal trends contributed to the findings, the demonstration of improved knowledge, 407 
reduced SRAEs and the low cost of this intervention support its widespread implementation. 408 
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Process feedback did not improve any of the study outcomes and deep sedation appeared 409 
to increase over time. The modelling highlighted that the greatest improvements occurred 410 
in those ICUs not randomised to receive process feedback, especially those in which 411 
responsiveness monitoring was implemented. There did not appear to be any interaction 412 
between process feedback and responsiveness monitoring either statistically or in 413 
qualitative data from the process evaluation. The reach and fidelity of process feedback 414 
among staff was limited and it did not seem to impact bedside practice. We did not pre-415 
define how the data should be used by ICUs and despite local meetings and champions it 416 
was poorly understood and lacked credibility with staff. Process control charts may be 417 
useful for tracking sedation-analgesia quality over time in response to sequential quality 418 
improvement initiatives, but our data suggest they are not effective in isolation.  419 
The reasons that education and process feedback had no effect on the sedation-analgesia 420 
quality outcome were informed by our mixed-methods process evaluation. Quality 421 
improvement theory emphasises the need for interventions that engage staff in change 422 
especially in complex healthcare environments such as ICUs.15 Although we included 423 
strategies to support implementation, staff perceived  process feedback as too remote from 424 
the bedside and lacked relevance to individual patient management. In most ICUs staff did 425 
not appear to feel ownership of data, and often disbelieved “negative” findings. Education 426 
was positively perceived and improved knowledge, but it is possible that this was 427 
insufficient to change behaviours consistently and could have been limited by factors such 428 
as support from senior clinicians or perceived effect on workload. Although ICU-level effects 429 
on the sedation-analgesia quality outcome did not occur, the reduction in SRAEs suggested 430 
some behaviour change did occur. Responsiveness may have been more effective because it 431 
was present at the bedside and provided objective evidence to support clinical decision-432 
making, thereby alleviating individual responsibility. Alternatively, the data may also have 433 
challenged clinicians resistant to change because the data were visible to colleagues. These 434 
mechanisms were supported by the process evaluation, which also suggested greater 435 
benefit might be possible with greater engagement with the technology.  436 
Our primary outcome was the first integrated sedation-analgesia quality measure to include 437 
freedom from deep sedation, agitation, pain/discomfort, and poor ventilator 438 
synchronisation. Previous trials have used length of stay outcomes rather than patient 439 
17 
 
comfort.6,7,24-26 In some of these trials the control groups were more deeply sedated than is 440 
current practice which may have inflated treatment effects, emphasising the importance of 441 
context and concurrent process evaluation in trials of complex healthcare interventions.27 442 
We chose sedation-analgesia quality as our primary outcome because this is important to 443 
patients, as highlighted in a recent UK public/professional priority setting partnership.8 444 
Baseline period data in our trial showed that freedom from excessive sedation was already 445 
present for 81% of care periods, suggesting the ICUs were already using a practice more 446 
consistent with evidence-based guidelines.3 This is another possible explanation for the 447 
relatively small absolute treatment effects we observed. We found no differences in length 448 
of ventilation or ICU stay, but our trial was not powered for these outcomes and the 449 
baseline practice decreased the plausibility of a large effect on these outcomes. The 450 
improvements in sedation-analgesia and patient safety associated with education and 451 
responsiveness monitoring are potentially clinically relevant, especially if greater uptake 452 
than achieved in the trial were achieved through improved implementation strategies.  453 
We used a cluster randomised design to compare the three interventions. This was efficient, 454 
enabled incorporation of baseline and intervention data from each ICU and a concurrent 455 
comparison of the effectiveness of the interventions. However, our trial has limitations. We 456 
could not blind clinical staff, which increased the risk of performance bias. We tried to 457 
minimise this by making relevant data recording part of routine care, analysing it remotely, 458 
concealing outcomes from staff (except when communicated as part of the process 459 
feedback intervention), and collecting a large volume of outcome data over a prolonged 460 
period. A sensitivity analysis undertaken using data collected >15 weeks after implementing 461 
interventions showed similar results suggesting sustained effects. The requirement for 462 
consent from a surrogate decision-maker was unavoidable within the Scottish legal/ethical 463 
system but increased the possibility of enrolment bias. We minimised this by randomising 464 
entire clusters and using the same consent process throughout the trial. This enriched the 465 
study population with patients requiring longer term ventilation, in whom the plausibility 466 
for effectiveness was highest. For example, the median duration of mechanical ventilation in 467 
the study population was 4 days compared to 2 days for all mechanically ventilated patients 468 
in participating ICUs (based on ICU audit data; see http://www.sicsag.scot.nhs.uk). Although 469 
we adjusted for relevant patient-level factors we cannot exclude the possibility of 470 
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unmeasured confounding variables. We also included a relatively small number of ICUs, 471 
especially for exploring several interventions, and it is impossible to exclude some temporal 472 
effect on the evaluation of online education with the design used. Variation between ICUs at 473 
baseline and differences in uptake and implementation of the interventions, which was 474 
suggested by the qualitative process evaluation, could also have been important. These 475 
issues are difficult to avoid in pragmatic cluster trials, but modelling enabled an estimation 476 
of overall effects. Our study illustrates the importance of a process evaluation in trials of 477 
complex healthcare interventions, to provide explanatory data to understand the effects 478 
observed.27  479 
In conclusion, we have shown that continuous responsiveness monitoring can improve 480 
overall optimum sedation-analgesia quality in mechanically ventilated critically ill patients 481 
and that online staff education can decrease SRAEs. These interventions appear to have 482 
beneficial effects on staff behaviours in relation to sedation-analgesia and combining them 483 
may improve sedation-analgesia quality and patient safety in ICUs. 484 
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 560 
Research in context 561 
Evidence before this study 562 
We searched Pubmed, Medline and the Cochrane Database of Systematic Reviews database 563 
without language or date restrictions for published research that evaluated interventions to 564 
improve sedation and analgesia quality for mechanically ventilated intensive care patients. 565 
We also searched recently published guidelines relevant to sedation and analgesia 566 
management. The most recent search was done on January 27th 2016. Published trials focus 567 
on avoidance of deep sedation rather than integrated measures of sedation depth, pain, 568 
and agitation. Recent research with patients suggests optimising overall comfort is 569 
important, and observational research indicates pain and discomfort are prevalent. The 570 
primary outcome for most randomised trials was length of mechanical ventilation or ICU 571 
stay rather than patient-focussed outcomes. Two recent Cochrane reviews summarised 572 
existing RCT evidence. Aitken found that evidence supporting protocol-driven sedation did 573 
not support effectiveness for reducing duration of ventilation or ICU stay. Burry did not find 574 
strong evidence to support daily sedation interruptions for reducing duration of ventilation 575 
or ICU stay. Both studies highlighted the importance of the context and setting for 576 
understanding the generalisability of trial results. Although some sedation-monitoring 577 
technologies exist, they are largely designed for depth of anaesthesia monitoring and their 578 
discriminant value is limited for ICU sedation. Existing technologies have not been tested in 579 
large randomised trials. 580 
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Added value of this study 581 
This cluster randomised trial evaluated the effects of three differing interventions that 582 
might improve sedation-analgesia quality in mechanically ventilated patients: an online 583 
educational programme for staff, the regular feedback of data about ongoing sedation-584 
analgesia quality, and a novel sedation-monitoring technology (Responsiveness Index) 585 
developed as a continuous alert for possible deep sedation. The study used sedation-586 
analgesia quality as the primary outcome, whose components were the absence of 587 
unnecessary deep sedation, agitation, and two discomfort behaviours (poor relaxation and 588 
poor synchronisation with the ventilator). An embedded process evaluation showed 589 
variation in the reach and uptake of the interventions between ICUs, despite clear 590 
implementation strategies. Despite this, we found that the Responsiveness Index 591 
monitoring was most effective at increasing rates of optimum sedation, mainly by 592 
decreasing deep sedation and poor ventilator synchronisation. We found that education did 593 
not change the primary outcome but improved patient safety by decreasing sedation-594 
related adverse events. Regular feedback of sedation-analgesia quality data alone did not 595 
improve quality. 596 
Implications of all the available evidence 597 
Our findings suggest that using continuous Responsiveness Index monitoring can help 598 
decrease deep sedation and improve overall optimum sedation. Combining this with system 599 
level staff education may enable ICUs to decrease deep sedation while maintaining patient 600 
safety. This approach might overcome some of the barriers to changing sedation practice in 601 
ICUs. A trial designed to determine whether Responsiveness Index monitoring can improve 602 
outcomes such as length of stay and cost-effectiveness in addition to sedation-analgesia 603 
quality is justified 604 
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TABLES 
Table 1: Total number of care periods with data available on each sedation-analgesia quality measure during baseline period for all eight 
participating ICUs, along with the number and percentage of care periods with optimum sedation-analgesia and each component of the 
primary outcome. 
 
Sedation-Analgesia Quality Measure 
Total number of 
evaluable care periods 
Number of care periods 
with measure 
% of care periods with 
measure 
Primary Outcome 
Optimum Sedation 9187 5150 56·1 
Components of Primary Outcome 
Free from Excessive Sedation 9319 7510 80·6 
Free from Agitation 9274 8360 90·1 
Free from Poor Relaxation 9362 7744 82·7 
Free from Poor Synchronisation 9335 8331 89·2 
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Table 2A: Estimates of effects of each intervention on the sedation-analgesia quality measures at patient level. A rate ratio (RR) >1 indicates an 
increase in the outcome with the intervention (improvement). 
 
  Education Process Feedback 
Responsiveness 
Monitoring 
Sedation-Analgesia Quality Outcomes at Patient Level  
Optimum Sedation RR (95% CI) 1·02 (0·92-1·13) 0·90 (0·80-1·01) 1·17 (1·04-1·31) 
Free from Excessive Sedation RR (95% CI) 1·02 (0·96-1·08) 0·90 (0·84-0·97) 1·09 (1·01-1·17) 
Free from Agitation RR (95% CI) 1·02 (0·96-1·08) 1·02 (0·95-1·09) 0·98 (0·91-1·05) 
Free from Poor Relaxation RR (95% CI) 0·98 (0·92-1·04) 0·98 (0·91-1·05) 1·05 (0·98-1·13) 
Free from Poor Synchronisation RR (95% CI) 1·00 (0·95-1·07) 0·99 (0·92-1·06) 1·04 (0·97-1·11) 
 
Note: Outcomes with statistically significant intervention effects (95% confidence intervals (CIs) do not overlap 1) are highlighted in bold. Results are from generalised 
linear model with log link and negative binomial error distribution for number of DESIST care periods with an outcomes present for each patient, using the total number of 
DESIST care periods with valid data for that outcome for each patient as an offset. Adjusted for age, sex and APACHE II score. 
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Table 2B: Estimates of effects of each intervention on the sedative and analgesic drug use outcomes. A ratio of geometric means (RoGM) or 
odds ratio (OR) <1 indicates a decrease in the outcome with the intervention (improvement). 
 
  Education Process Feedback 
Responsiveness 
Monitoring 
Sedative and Analgesic Drug Use 
Propofol Equivalents Used (mg) RoGM (95% CI) 1·09 (0·85-1·40) 1·01 (0·77-1·34) 1·01 (0·76-1·34) 
Alfentanil Equivalents Used (mg) RoGM (95% CI) 1·06 (0·83-1·35) 1·05 (0·80-1·38) 1·18 (0·90-1·55) 
Day on which ≥4000mg Propofol        
(or equivalents) Administered OR (95% CI) 0·43 (0·22-0·86) 2·45 (1·11-5·42) 1·11 (0·52-2·38) 
Patient Received Haloperidol OR (95% CI) 1·18 (0·74-1·89) 0·95 (0·56-1·63) 1·14 (0·68-1·91) 
 
Note: Outcomes with statistically significant intervention effects (95% confidence intervals (CIs) do not overlap 1) are highlighted in bold. Results are from normal linear 
model for log-transformed propofol and alfentanil equivalents, mulitlevel generalised linear model with logit link for day on which ≥4000mg propofol (or equivalents) 
administered, and generalised linear model with logit link for patient received haloperidol. Adjusted for age, sex and APACHE II score. 
 
  
26 
 
Table 2C: Estimates of effects of each intervention on patient outcomes. For mortality outcomes an odds ratio (OR) <1 indicates a reduction in 
mortality with the intervention (improvement). For the time to event outcomes a hazard ratio (HR) >1 indicates an increased risk of the event 
with the intervention (improvement), which corresponds to a shorter duration of mechanical ventilation, ICU stay, or hospital stay.  
 
  Education Process Feedback 
Responsiveness 
Monitoring 
Mortality 
ICU OR (95% CI) 1·19 (0·73-1·93) 1·33 (0·77-2·29) 0·78 (0·46-1·35) 
Hospital OR (95% CI) 1·08 (0·68-1·72) 1·08 (0·65-1·81) 0·82 (0·50-1·37) 
Time-To-Event Outcomes 
Cessation of Mechanical Ventilation  HR (95% CI) 0·92 (0·76-1·12) 1·00 (0·80-1·24) 0·87 (0·70-1·08) 
Discharge from ICU HR (95% CI) 0·89 (0·71-1·11) 0·98 (0·77-1·26) 0·92 (0·71-1·17) 
Discharge from Hospital HR (95% CI) 0·88 (0·70-1·11) 1·15 (0·89-1·48) 1·03 (0·79-1·33) 
 
Note: Outcomes with statistically significant intervention effects (95% confidence intervals (CIs) do not overlap 1) are highlighted in bold. Results are from generalised 
linear model with logit link for ICU and hospital mortality and a Cox proportional hazards model for time to event outcomes (durations of mechanical ventilation, ICU and 
hospital stay). Adjusted for age, sex and APACHE II score. The proportional hazards assumption was assessed by testing for a non-zero slope over time on the basis of 
Schoenfeld residuals. 
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Table 3: Predicted percentages from modelling effects of intervention(s) on sedation-analgesia quality measures at care period level and 
sedation-related adverse event (SRAE) outcomes.  
 Baseline Education 
Education + 
Process Feedback 
Education +  
Responsiveness 
Monitoring 
Sedation-Analgesia Quality Measure at Care Period Level 
Primary Outcome 
Optimum Sedation 61·6% 64·4% 57·1% 72·3% 
Components of Primary Outcome 
Free from Excessive Sedation 85·5% 86·5% 80·6% 91·0% 
Free from Agitation 97·3% 97·6% 98·1% 97·2% 
Free from Poor Relaxation 90·3% 88·6% 88·4% 90·7% 
Free from Poor Synchronisation 94·5% 94·8% 94·3% 96·6% 
Sedation-Related Adverse Events 
Day on which a SRAE Occurred 2·0% 1·1% 1·1% 1·9% 
Patient Experienced a SRAE 17·6% 10·7% 12·1% 18·6% 
 
Note: Predictions are for the average ICU patient enrolled in the study (age 60 years, 60% male, APACHE II score 22). 
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Figure 1: Modified CONSORT diagram to show the flow of patients included in each ICU during the 
baseline and intervention periods of the study, together with characteristics of the patients. Further 
detailed screening data are included in the supplementary material (Table S3).  
 
Figure 2: Estimates of effects of each intervention, odds ratios (OR) and 95% confidence intervals, on 
sedation-analgesia quality measures at care period level and sedation-related adverse event (SRAE) 
outcomes. For the sedation-analgesia quality measures an OR >1 indicates an increase in the 
outcome with the intervention (improvement); for the SRAE outcomes an OR <1 indicates a decrease 
in the outcome with the intervention (improvement).  
Note: Results are from multilevel generalised linear model with logit link for sedation-analgesia 
quality measures and SRAE at day level, and generalised linear model with logit link for SRAE at 
patient level. Adjusted for age, sex, and APACHE II score. 
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A cluster randomised trial of staff education, regular sedation-analgesia quality feedback, 
and a sedation monitoring technology for improving sedation-analgesia quality for 
critically ill mechanically ventilated patients (DESIST trial). 
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Table S1: Summary of the sedation and pain assessment tools used by each of the ICUs, and their approach to using sedation holds and/or reducing 
sedation prior to starting the trial. 
 Education 
Education +                           
Process Feedback 
Education +          
Responsiveness Monitoring 
Education +                        
Process Feedback + 
Responsiveness Monitoring 
 ICU1 ICU2 ICU3 ICU4 ICU5 ICU6 ICU7 ICU8 
Sedation 
assessment tool 
RASS RAMSAY RASS RASS RASS SAS RASS RASS 
Delirium 
monitoring 
CAM-ICU twice 
daily 
NO CAM-ICU twice 
daily 
CAM-ICU twice 
daily 
NO No consistency CAM-ICU CAM-ICU 
Pain assessment 
tool for 
mechanically 
ventilated 
patients 
NO  NO NO Used in 
epidurals 
NO NO NO Visual Analogue 
Scale 
Sedation hold 
strategy 
No consistency 
in sedation hold 
practice. 
Sedation hold 
performed as 
part of VAP 
bundle. Gradual 
reduction of 
sedation. Not 
protocolized. 
Done at 8am 
daily as part of 
VAP bundle.  
No consistency 
in sedation hold 
practice. 
Individualised 
approach. 
Sedation hold 
performed as 
part of VAP 
bundle. 
Individualised 
approach to 
sedation hold. 
Not 
protocolized. 
Sedation hold 
performed as 
part of VAP 
bundle. 
Individualised 
approach to 
sedation hold. 
Not 
protocolized. 
Sedation hold 
performed as 
part of VAP 
bundle.  
Individualised 
approach to 
sedation hold. 
Not 
protocolized. 
Sedation hold 
performed as 
part of VAP 
bundle.  
Individualised 
approach to 
sedation hold. 
Sedation hold 
protocol 
available.  
Individualised 
approach to 
sedation hold. 
Not 
protocolized. 
Sedation hold 
performed as 
part of VAP 
bundle.  
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Table S2: Detailed breakdown of the diagnostic categories of the patients enrolled in the study at each ICU during each study period. All values are N (%). 
 Education 
Education +             
Process Feedback 
Education +  
Responsiveness 
Monitoring 
Education +            
Process Feedback + 
Responsiveness 
Monitoring 
Diagnostic 
Category 
Study  
Period ICU1 ICU2 ICU3 ICU4 ICU5 ICU6 ICU7 ICU8 
Cardiovascular Baseline 38 (32·2%) 29 (29·6%) 83 (35·2%) 34 (33·3%) 30 (28·0%) 15 (24·6%) 18 (20·7%) 12 (16·7%) 
Intervention 20 (30·8%) 16 (27·6%) 60 (35·7%) 25 (46·3%) 9 (14·5%) 7 (25·0%) 18 (16·4%) 8 (18·6%) 
Respiratory Baseline 34 (28·8%) 39 (39·8%) 46 (19·5%) 32 (31·4%) 32 (29·9%) 26 (42·6%) 25 (28·7%) 32 (44·4%) 
Intervention 16 (24·6%) 12 (20·7%) 31 (18·5%) 8 (14·8%) 24 (38·7%) 15 (53·6%) 36 (32·7%) 16 (37·2%) 
Gastrointestinal Baseline 17 (14·4%) 15 (15·3%) 73 (30·9%) 11 (10·8%) 26 (24·3%) 11 (18·0%) 24 (27·6%) 14 (19·4%) 
Intervention 15 (23·1%) 13 (22·4%) 54 (32·1%) 10 (18·5%) 20 (32·3%) 5 (17·9%) 24 (21·8%) 11 (25·6%) 
Trauma Baseline 6 (5·1%) 0 (0·0%) 4 (1·7%) 12 (11·8%) 4 (3·7%) 0 (0·0%) 4 (4·6%) 2 (2·8%) 
Intervention 2 (3·1%) 0 (0·0%) 10 (6·0%) 4 (7·4%) 1 (1·6%) 0 (0·0%) 8 (7·3%) 1 (2·3%) 
Neurological Baseline 10 (8·5%) 6 (6·1%) 12 (5·1%) 7 (6·9%) 7 (6·5%) 1 (1·6%) 10 (11·5%) 4 (5·6%) 
Intervention 3 (4·6%) 6 (10·3%) 4 (2·4%) 4 (7·4%) 1 (1·6%) 0 (0·0%) 11 (10·0%) 3 (7·0%) 
Obstetrics Baseline 0 (0·0%) 1 (1·0%) 0 (0·0%) 0 (0·0%) 0 (0·0%) 0 (0·0%) 1 (1·1%) 0 (0·0%) 
Intervention 0 (0·0%) 0 (0·0%) 1 (0·6%) 0 (0·0%) 0 (0·0%) 0 (0·0%) 1 (0·9%) 0 (0·0%) 
Self-Inflicted 
Overdose 
Baseline 4 (3·4%) 2 (2·0%) 8 (3·4%) 2 (2·0%) 3 (2·8%) 6 (9·8%) 1 (1·1%) 2 (2·8%) 
Intervention 4 (6·2%) 3 (5·2%) 4 (2·4%) 2 (3·7%) 2 (3·2%) 1 (3·6%) 2 (1·8%) 1 (2·3%) 
Miscellaneous 
Diagnoses 
Baseline 7 (5·9%) 4 (4·1%) 8 (3·4%) 4 (3·9%) 5 (4·7%) 1 (1·6%) 4 (4·6%) 2 (2·8%) 
Intervention 3 (4·6%) 5 (8·6%) 4 (2·4%) 1 (1·9%) 1 (1·6%) 0 (0·0%) 7 (6·4%) 2 (4·7%) 
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Renal Diagnosis Baseline 2 (1·7%) 2 (2·0%) 2 (0·8%) 0 (0·0%) 0 (0·0%) 1 (1·6%) 0 (0·0%) 4 (5·6%) 
Intervention 2 (3·1%) 3 (5·2%) 0 (0·0%) 0 (0·0%) 4 (6·5%) 0 (0·0%) 3 (2·7%) 1 (2·3%) 
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Table S3: Detailed summary of the numbers of patients in screening and inclusion processes for each ICU during the baseline and intervention periods. 
 
 
Education 
Education +                    
Process Feedback 
Education +       
Responsiveness 
Monitoring 
Education +                
Process Feedback + 
Responsiveness 
Monitoring 
ICU 1 ICU2 ICU3 ICU4 ICU5 ICU6 ICU7 ICU8 
BA
SE
LI
N
E 
PE
RI
O
D 
(4
5 
W
EE
KS
) 
SCREENED (N) 1225 483 1015 408 374 282 722 315 
EXCLUDED 1019 293 562 134 239 141 499 209 
Died 17 23 30 10 8 16 3 5 
Age <16 years 13 3 5 8 11 2 4 0 
For palliative care 8 1 1 1 0 1 2 1 
No mechanical ventilation 894 162 272 27 153 55 343 54 
Mechanical ventilation 
discontinued at time of 
screening 
49 67 139 33 31 36 109 33 
Extubation anticipated 
within 4 hours of screening 19 28 73 34 26 22 25 84 
Decision made to withdraw 
treatment 14 1 15 18 10 6 9 31 
Already enrolled in the 
study during current 
hospital admission 
5 8 27 3 0 3 4 1 
ELIGIBLE 206 190 453 274 135 141 223 106 
CONSENTED                     
(% of eligible patients) 120 (58) 98 (52) 236 (52) 103 (38) 108 (80) 61 (43) 92 (41) 74 (70) 
Reason not consented         
No one available to provide 
consent 17 31 34 24 3 6 48 10 
Lack of research staff 3 0 32 47 0 5 1 0 
Not approached 21 1 37 19 10 23 24 6 
Clinician refusal 2 24 18 8 0 2 9 6 
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Consent not obtained within 
48 hours of admission 32 22 79 44 4 27 35 6 
Other 11 14 17 29 10 17 14 4 
EXCLUDED FROM ALL 
ANALYSES (status epilepticus) 2 0 0 1 1 0 5 2 
PRIMARY OUTCOME 
DATA AVAILABLE 113 91 232 101 104 61 78 67 
Reason for no primary 
outcome data            
Mechanical ventilation for 
<48 hours 3 5 4 0 3 0 7 4 
Receiving neuromuscular 
paralysis 2 1 0 0 0 0 0 1 
No SQATs completed 0 1 0 1 0 0 2 0 
 
 
Education 
Education +                
Process Feedback 
Education +      
Responsiveness 
Monitoring 
Education +                 
Process Feedback + 
Responsiveness 
Monitoring 
ICU 1 ICU2 ICU3 ICU4 ICU5 ICU6 ICU7 ICU8 
IN
TE
RV
EN
TI
O
N
 P
ER
IO
D 
(4
5 
W
EE
KS
) SCREENED (N) 1105 369 944 345 244 191 394 209 
EXCLUDED 987 249 638 182 154 110 193 146 
Died 27 23 18 23 3 17 4 0 
Age <16 years 8 3 2 2 4 0 2 0 
For palliative care 6 0 1 0 0 0 2 0 
No mechanical ventilation 866 123 302 33 102 28 84 48 
Mechanical ventilation 
discontinued at time of 
screening 
37 54 178 74 33 42 55 50 
Extubation anticipated 
within 4 hours of screening 42 29 112 31 11 21 33 30 
Decision made to withdraw 
treatment 0 13 22 15 1 2 10 11 
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Already enrolled in the 
study during current 
hospital admission 
1 4 3 4 0 0 3 7 
ELIGIBLE 118 120 306 163 90 81 201 63 
CONSENTED                     
(% of eligible patients) 65 (55) 58 (48) 170 (56) 55 (34) 62 (69) 28 (35) 116 (58) 44 (70) 
Reason not consented         
No one available to provide 
consent 6 11 25 8 2 11 10 2 
Lack of research staff 4 6 6 17 0 0 4 0 
Not approached 2 9 13 46 3 4 8 1 
Clinician refusal 0 17 10 3 0 1 1 0 
Consent not obtained within 
48 hours of admission 23 5 25 5 1 31 26 0 
Other 18 14 57 29 22 6 36 16 
EXCLUDED FROM ALL 
ANALYSES (status epilepticus) 0 0 2 1 0 0 4 0 
PRIMARY OUTCOME 
DATA AVAILABLE 
64 56 167 52 61 28 107 42 
Reason for no primary 
outcome data           
Mechanical ventilation for 
<48 hours 1 1 1 1 1 0 4 0 
Receiving neuromuscular 
paralysis 0 0 0 0 0 0 1 2 
No SQATs completed 0 1 0 1 0 0 0 0 
 
Note: SQAT, sedation quality assessment tool. 
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Figure S1: Estimates of joint effects of interventions, odds ratios (OR) and 95% confidence intervals, in each ICU on sedation-analgesia quality measures at DESIST care 
period level from modelling, prior to pooled analysis. An OR >1 indicates an increase in outcome with the intervention(s) (improvement).  
   
 
 
Note: Results are from a generalised linear model with logit link. Adjusted for age, sex and APACHE II score.
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Table S4: Number of patients and number of care periods with data available on primary outcome (optimum sedation-analgesia), and number of care 
periods with optimum sedation-analgesia by intervention group and study period. All data presented are raw data before modelling. 
 Baseline period Intervention period 
Intervention 
Patients     
(N) 
Care periods 
(N) 
Care periods with 
optimum sedation 
(N (%)) 
Patients    
(N) 
Care periods 
(N) 
Care periods with 
optimum sedation 
(N (%)) 
Education 847 9187 5150 (56·1) 577 6947 3940 (56·7) 
Process Feedback              
        Implemented 
        Not Implemented 
 
478 
369 
 
5383 
3804 
 
2930 (54·4) 
2220 (58·4) 
 
368 
209 
 
4725 
2222 
 
2526 (53·5) 
1414 (63·6) 
Responsiveness Monitoring  
        Implemented 
        Not Implemented 
 
310 
537 
 
2902 
6285 
 
1486 (51·2) 
3664 (58·3) 
 
238 
339 
 
2858 
4089 
 
1663 (58·2) 
2277 (55·7) 
 
Note: There were 42 and 15 patients from the baseline and intervention periods respectively for whom the APACHE II score was imputed. Only 1 and 3 patients from the 
baseline and intervention periods respectively were excluded from statistical modelling due to missing covariate(s). 
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Table S5: Intraclass correlation coefficients (ICCs) for the primary outcome and the two-level 
secondary outcomes. 
Outcome ICC 
Sedation-Analgesia Quality Measures at Care Period Level 
Primary Outcome 
Optimum Sedation 0·25 
Components of Primary Outcome 
Free from Excessive Sedation 0·34 
Free from Agitation 0·40 
Free from Poor Relaxation 0·29 
Free from Poor Synchronisation 0·27 
Sedation-Related Adverse Events 
Day on which a Sedation-Related Adverse Event (SRAE) 
occurred 0·21 
Sedative and Analgesic Drug Use 
Day on which ≥4000mg Propofol (or equivalents) administered 0·60 
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Table S6: Sensitivity analyses exploring effects of each intervention based on those patients enrolled during final 30 weeks of the intervention period. 
Table S6(a): Estimates of effects on sedation-analgesia quality measures at DESIST care period level. An odds ratio (OR) >1 indicates an increase in the 
outcome with the intervention (improvement). 
  Education Process Feedback 
Responsiveness 
Monitoring 
Primary Outcome 
Optimum Sedation OR (95% CI) 1·14 (0·83-1·57) 0·66 (0·46-0·94) 1·51 (1·06-2·16) 
Components of Primary Outcome 
Free from Excessive Sedation OR (95% CI) 1·12 (0·75-1·65) 0·57 (0·36-0·89) 1·55 (1·00-2·38) 
Free from Agitation OR (95% CI) 1·27 (0·71-2·26) 1·01 (0·53-1·94) 0·83 (0·46-1·50) 
Free from Poor Relaxation OR (95% CI) 0·77 (0·52-1·13) 0·96 (0·63-1·46) 1·35 (0·89-2·05) 
Free from Poor Synchronisation OR (95% CI) 1·23 (0·83-1·83) 0·78 (0·49-1·24) 1·84 (1·19-2·85) 
 
Note: Outcomes with statistically significant intervention effects (95% confidence intervals (CIs) do not overlap 1) are highlighted in bold. Results are from multilevel 
generalised linear model with logit link. Adjusted for age, sex and APACHE II score. 
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Table S6(b): Estimates of effects on sedation-analgesia quality measures at patient level. A rate ratio (RR) >1 indicates an increase in the outcome with the 
intervention (improvement).  
 Education Process Feedback 
Responsiveness 
Monitoring 
Optimum Sedation RR (95% CI) 1·03 (0·92-1·15) 0·86 (0·75-0·98) 1·17 (1·02-1·35) 
Free from Excessive Sedation RR (95% CI) 1·02 (0·95-1·10) 0·88 (0·81-0·96) 1·07 (0·98-1·16) 
Free from Agitation RR (95% CI) 1·02 (0·96-1·09) 1·02 (0·94-1·10) 0·97 (0·90-1·05) 
Free from Poor Relaxation RR (95% CI) 0·97 (0·91-1·04) 0·97 (0·89-1·05) 1·05 (0·96-1·14) 
Free from Poor Synchronisation RR (95% CI) 1·02 (0·95-1·09) 0·98 (0·90-1·06) 1·05 (0·97-1·14) 
 
Note: Outcomes with statistically significant intervention effects (95% confidence intervals (CIs) do not overlap 1) are highlighted in bold. Results are from generalised 
linear model with log link and negative binomial error distribution for number of DESIST care periods with an outcomes present for each patient, using the total number of 
DESIST care periods with valid data for that outcome for each patient as an offset. Adjusted for age, sex and APACHE II score. 
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Table S6(c): Estimates of effects on sedation related adverse event (SRAE) outcomes. An odds ratio (OR) <1 indicates a decrease in the outcome with 
intervention (improvement). 
 Education Process Feedback 
Responsiveness 
Monitoring 
Day on which a SRAE Occurred OR (95% CI) 0·61 (0·33-1·13) 0·85 (0·42-1·72) 2·23 (1·09-4·57) 
Patient Experienced a SRAE OR (95% CI) 0·55 (0·30-1·04) 1·04 (0·52-2·08) 2·54 (1·25-5·15) 
 
Note: Outcomes with statistically significant intervention effects (95% confidence intervals (CIs) do not overlap 1) are highlighted in bold. Results are from multilevel 
generalised linear model with logit link for SRAE at day level and a generalised linear model with logit link for SRAE at patient level. Adjusted for age, sex and APACHE II 
score. 
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CHANGES TO ORIGINAL ANALYSIS PLAN 
In analysing the four components (excessive sedation; agitation; poor relaxation; poor ventilator 
synchronisation) of optimum sedation-analgesia we inverted these to model at care period level 
those which were free from excessive sedation, free from agitation, free from poor relaxation and 
free from poor ventilator synchronisation, and at patient level the number of care periods free from 
excessive sedation, free from agitation, free from poor relaxation and free from poor ventilator 
synchronisation. This clarified the presentation of the analysis by ensuring that an odds ratio or rate 
ratio >1 represented a favourable effect for both optimum sedation and each of the four 
components. [Figure 2, Tables 2A, S6(a), S6(b)] 
 
For the analysis of optimum sedation and its components at patient level, we used a generalised 
linear model with log link but a negative binomial rather than the Poisson error distribution that was 
originally planned. This accounted appropriately for the unexpected over-dispersion observed in 
these outcomes. [Tables 2A, S6(b)] 
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PROCESS EVALUATION 
 
Aim 
A key goal of the process evaluation was to understand whether the interventions were 
implemented as planned, the barriers to implementation, and factors that worked well/less well. We 
planned a priori to compare effects between ICUs in which successful engagement and 
implementation appeared to occur versus those with less successful engagement and 
implementation. The cluster randomised design of DESIST allowed this comparison. The analysis 
strategy was a mixed methods approach in which qualitative data were used to provide context and 
explanation of the quantitative findings.  
 
Education intervention 
A total of 538 nurses completed the training. The eight ICUs achieved 74%, 80%, 80%, 96%, 96%, 
98%, 100%, and 100% training completion of eligible nursing staff. The mean pre-training core 
knowledge test score (range 0-10) was 6.4 (SD 1.8). In total 394 nurses (73%) completed the re-test a 
median 32 weeks (1st-3rd quartile 28-39 weeks) after first test. The mean change in scores, adjusted 
for pre-test score, showed an increase of 0.82 (95% CI: 0.65-0.98; P<0.0001).  
 
Responsiveness monitoring 
In the four ICUs a total of 206 patients received RI monitoring (82% enrolled patients; range 76% to 
95% between ICUs). The median (1st, 3rd quartile) time between intubation and starting monitoring 
was 21 hours (11, 34) and median duration of monitoring was 66 hours (27, 139). The first RI 
recorded was: red 59% (range 50-66% across ICUs), amber 12% (range 4-17%), and green 28% (range 
25-38%). Among patients whose first RI was red 16% never had a green RI of whom 68% were ICU 
non-survivors. The median time to first recording a green RI when this occurred was 9 hours (4, 23). 
Among all patients the RI value was red for a median 35% of monitored time (range 23-48% across 
ICUs); the median longest recorded time with continuous red RI values within each patient was 7 
hours (3, 14). Together these data suggested significant periods of low RI values despite the 
instruction to adjust sedation to achieve a higher RI value in the amber or green range. 
 
Qualitative evaluation 
Qualitative data were collected both during the baseline, during the implementation phase, and 
during the intervention periods of the study. We conducted multi-professional focus groups in each 
ICU prior to the implementation phase to understand the current culture of sedation practice. 
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During the implementation period and intervention phase action research involving participant 
observation took place at each ICU at three distinct times to understand the uptake of the 
interventions and changes in practice: the end of implementation phase, midway during the 
intervention period, and at the end of the intervention period. We conducted multi-professional 
focus groups in the final month of the intervention period, in which participants reflected on the 
uptake of the intervention(s) and the changes to sedation practice. Data from field notes from 
participant observation and focus groups transcripts were verbatim transcribed and then checked 
for accuracy of transcription by the qualitative researcher (KK). Data were entered in NVivo 10 for 
windows software for qualitative analysis (QSR International, Ltd).  
Data were organised by ICU setting for coding. An inductive thematic analysis was conducted 
without a pre-defined theoretical framework to allow the in-depth exploration and understanding of 
the impact of interventions on sedation management. Constant comparison ensured that the 
thematic analysis represented all perspectives and negative cases were sought. Validity checking of 
the coding included recoding of data from 4 ICUs, representative of each intervention group, by an 
independent researcher (GH). Discordant coding and agreement was resolved by discussion within 
the wider research team.  
Data were extracted in relation to the characteristics of the interventions, its compatibility with the 
clinicians, its visibility in the clinical environment, any compelling attributes and the timing the 
intervention was introduced.  Data related to the dissemination and the adoption of the 
intervention(s) included the adopters’ intra-individual factors such as their expectations of the 
intervention(s), the meaning of the intervention to them, their learning style and their tolerance of 
ambiguity about the intervention. Elements of the clinicians’ communication channels, availability of 
linkage agents, their clinical routines and existing cultures (such as documentation processes, daily 
housekeeping processes), elements of the ICU environment (size, facilities), geography of the setting 
(floor plan, types of admissions due to the geographical area) informed the adoption of the 
interventions. Clinicians’ initial expectations of the interventions as well as their knowledge of the 
intervention, including awareness knowledge (that the innovation exists), procedural knowledge 
(how to use the intervention) and principles knowledge (how the intervention works) were 
considered. Although some strategies to implement the interventions were suggested, we recorded 
how clinicians adjusted these strategies to facilitate implementation of interventions. We recorded 
the barriers and facilitators to implementation and adoption, and the role of staff involvement, 
including leadership roles, teamwork elements, and communication channels. In this supplement we 
present the clinicians’ perceived feedback on the use of the three interventions and the response of 
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each ICU to the implementation of the interventions including any changes observed in their 
sedation-analgesia practice (Tables S7 and S8).  
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Table S7: Clinicians’ feedback on each intervention. 
 
Education Process Feedback Responsiveness Monitoring 
Positive comments Negative comments Positive comments Negative comments Positive comments Negative comments 
Informative and useful, in 
particular for junior staff. 
For senior nurses was a 
good reminder.  
Met educational needs of 
staff.  
Had a good summative 
assessment.  
Staff were familiar with 
the online platform used 
(LearnPro). 
 
Time consuming. 
Overwhelming for some 
junior staff. 
Some technical problems 
with access to the module 
delayed implementation 
(3 ICUs).  
Debatable format (e-form 
vs hard copies). 
Nurses needed feedback 
on the online assessments 
of knowledge.  
 
Stimulated discussion 
about suboptimum 
sedation.  
Used existing QI 
methodology and 
presentation familiar to 
the staff.  
 
Disbelief in how the 
process measures were 
derived. Nurses felt SQAT 
tool questions, from which 
the process measures 
were derived, were not 
relevant to some patient 
cases and did not reflect 
current practice. (i.e. felt 
agitation was more 
prevalent to excessive 
sedation).  
Process measures were 
not meaningful to nurses. 
Lack of understanding of 
the charts by the nurses. 
The process measures 
were not disseminated 
timely; they needed to be 
presented weekly to drive 
change.  
No consistent 
presentation.  
The style of presentation 
needed improvement.  
Monitor was easy to use 
and was a good prompt 
tool for some patient 
cases.  
Families found it useful.  
Used mainly as a research 
tool. 
 
 
Lack of understanding of 
the role of the monitor. 
Some nurses felt it was 
useless. 
There was no correlation 
of the monitor with the 
clinical picture in certain 
patients. Created disbelief. 
There was time lag 
between monitor 
recording and physical 
presentation of the 
patient.  
Non adhesive stickers - 
increased gaps in 
recording.  
Skin excoriation because 
of the stickers. 
Big size was a problem for 
small ICUs.  
Some faulty parts of the 
monitor.  
Families found it invasive.  
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Table S8: Perceived changes in sedation-analgesia practice due to each intervention. 
 
Education Process Feedback Responsiveness Monitoring 
Raised awareness of sedation-analgesia management, 
sleep promotion, drug properties, delirium and 
agitation, psychosis. Able to differentiate between 
sedation and analgesia management.  
Nurses felt more confident in their decision-making.  
Introduced sleep promotion initiatives.  
Re-enforced the use of sedation breaks and reviewing 
their timing.  
Introduced new tools for assessment of pain (CPOT), 
delirium (CAM-ICU), and sedation, where not available. 
Introduced/ updated protocols for management of 
sedation, agitation, delirium and pain.   
Considered introducing agents for managing psychosis 
and delirium.  
Recognised the need for improvement of sedation-
analgesia practice.  
Recognised the need for a standardised manner in 
managing sedation-analgesia.  
Raised awareness of suboptimum sedation practice.  
Introduced/ updated daily review of sedation-analgesia 
management and documentation where not available 
or not consistently performed.  
Introduced checklists (e.g. ICU pause) in ward round 
meetings or safety briefs as an aide-memoir tool to 
highlight sedation-analgesia issues regularly.  
Introduced audits on use of assessment tools, sleep 
quality, and pain.  
 
Used as a prompt tool to identify excessive sedation 
and detect sleep. Able to differentiate between sleep 
and sedation. 
Informed decisions about excessive sedation.  
Reviewed the use of sedation boluses as a 
management method for agitation, observing their 
effect on the monitor recording and the physical 
appearance of the patient.  
Identified the need to introduce a sleep promotion 
protocol.  
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Example of a full set of process feedback for one of the ICUs randomised to receive process 
feedback during the study 
SEDATION RELATED QUALITY MEASURES REPORT – 21st DECEMBER 2014 
Background 
The DESIST study is evaluating different approaches to improving the quality of sedation of intensive care 
patients. One of the approaches is to provide feedback on a range of quality indicators. This report provides 
you with information about the prevalence of excessive sedation, agitation, discomfort and sedation-related 
adverse events in your ICU. It also provides an overall measure of optimum sedation among patients. 
The information used to generate these reports was recorded by nursing staff using the Sedation Quality 
Assessment Tool (SQAT) forms for each nursing shift, and information collected by research staff for the 
DESIST study.   
How to use these reports 
The information included in this report is intended to help improve sedation management in your ICU by 
providing you with feedback on current sedation quality. We suggest that information is shared with all staff 
groups through a range of media such as e-mail, posters, quality briefs, and meetings. We suggest that 
reports are reviewed at medical and nursing staff meetings, quality improvement teams, M&M meetings, 
and/or other local meetings in your ICU. We also encourage you to disseminate the findings in daily practice, 
for example at handovers or ward rounds. We hope you will use the information to review current sedation 
management, and initiate interventions and changes that will improve all aspects of sedation management. 
These charts will help you to monitor the effect of your interventions and changes. 
The reports have been designed to illustrate changes over time, especially improvements or deterioration in 
performance for each quality measure. Reports will be circulated every 2 months, using recently collected 
data from the DESIST study. In this way the impact of local initiatives to improve management can be seen. 
We hope you will supplement these with local data collected more frequently; we have provided you with 
“toolkits” to do this. 
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Summary Points 
This is the final process measures report for the intervention period of DESIST. The report includes data 
from all patient cases entered to the database during the intervention period with resolved queries. It 
presents the last 2 months of recruitment.  
In October to November 2014: 
Proportion during  
October – November 2014 
Proportion during 
August – 
September 2014 
Effect on sedation quality 
Excessive sedation was present 
for 26% of care periods 
16% 10% HIGHER rate of excessive sedation       
 
Agitation was present for 7% 
of care periods 
11% 4% LOWER rate of agitation 
 
Poor relaxation (a measure of 
pain and discomfort) was 
present for 12% of care 
periods 
19.5% 7.5% LOWER rate of poor relaxation 
 
Poor ventilator synchronisation 
was present for 5% of care 
periods 
8.5% 3.5% LOWER rate of poor ventilator 
synchronisation 
 
4 sedation-related adverse 
events occurred during this 
period 
9 FEWER sedation-related adverse events 
 
Overall, optimum sedation 
was present for 62% of care 
periods 
61% 1% HIGHER rate of optimum sedation       
 
Understanding the charts 
This report includes a series of process control charts, each under a separate section. Each chart includes: 
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1. A summary of how the quality indicator has been calculated from your data. 
2. A baseline proportion. Depending on the type of chart, this is the average value for the quality 
indicator during your baseline “pre-intervention” period (the data collected during the first 11 
months of the DESIST study, from October 2012 to August 2013).  
3. Process “warning” and “control” limits. These upper and lower limits are calculated to assess 
whether the rate of the quality indicator has changed significantly in your ICU. If a warning limit is 
exceeded it means the quality indicator is in danger of moving “out of control” compared to the 
baseline rate. This could be good or bad depending on the direction of change. If a control limit is 
crossed, this probably means there has been a “real” change in the measure compared to the 
baseline rate. This might indicate a significant improvement or deterioration in the measure 
according to the direction of change. 
4. Data points. A data point is included for every 2 months throughout the pre-intervention (baseline) 
and post-intervention periods for most charts. Each data point uses the available data from patients 
enrolled in the DESIST study for that period. 
 
Charts 
The following charts are included in this report: 
P charts: these charts show the proportion of nursing shifts (12 hour periods) for which the quality indicator 
was reported. 
• Proportion of periods with excessive sedation 
• Proportion of periods with agitation 
• Proportion of periods for which patient poorly relaxed 
• Proportion of periods with poor ventilator synchronisation  
• Proportion of periods with optimum sedation 
 
G charts: these charts show the number of patients managed between the quality indicator events 
occurring. 
 
• Number of patients treated without a sedation-related adverse event 
 
Sedation-related adverse events 
• Frequency table of all sedation related adverse events recorded during this period 
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“Proportion of periods with excessive sedation” 
How was this chart made? 
The data recorded by nurses on the SQAT form at the end of each shift was used to count the number of 
periods for which deep sedation was present. Information included on the SQAT form was used to exclude 
periods where deep sedation may have been appropriate, for example advanced ventilation, therapeutic 
hypothermia, or brain injury. The remaining periods were considered excessive sedation, because evidence 
would suggest these patients benefit from “lighter” sedation. Each data point has used 2 months of ICU 
admissions participating in the DESIST study. 
 
 
What does this chart mean? 
The proportion is the average rate of this quality measure that occurred in your ICU during the intervention 
period October to November 2014 in the DESIST study. This means that for 26% of care periods in the ICU 
excessive sedation was present using the DESIST definition. 
The observed proportion is the rate of excessive sedation over 2 months of observations in the ICU. If the 
proportion moves closer to the upper warning or control limit, the occurrence of excessive sedation is 
increasing. If it crosses the upper control limit this represents a significant increase in excessive sedation in 
your ICU. If the proportion moves closer to the lower warning or control limit, the occurrence of excessive 
sedation is decreasing. If it crosses the lower control limit this represents a significant decrease in excessive 
sedation in your ICU. 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
18/10/2012 - 
30/11/2012 
01/12/2012 - 
31/01/2013 
01/02/2013 - 
31/03/2013 
01/04/2013 - 
31/05/2013 
01/06/2013 - 
31/07/2013 
01/08/2013 - 
30/09/2013 
01/10/2013 - 
30/11/2013 
01/12/2013 - 
31/01/2014 
01/02/2014 - 
31/03/2014 
01/04/2014 - 
31/05/2014 
01/06/2014 - 
31/07/2014 
01/08/2014 - 
30/09/2014 
01/10/2014 - 
30/11/2014 
%
 o
f 
S
Q
A
T
 p
er
io
d
s 
Time period 
Excessive sedation was present for 26% of care 
periods 
Observed 
Proportion 
Upper Control 
Limit 
Upper Warning 
Limit 
Baseline 
Proportion 
Lower Warning 
Limit 
Lower Control 
Limit 
Start of Transition 
Period 
End of Transition 
Period 
24 
 
This chart suggests there has been INCREASE in excessive sedation during the period October to November 
2014. 
To learn more about the importance of excessive sedation and how to avoid it, access the DESIST LearnPro 
education package, modules 1 (Why is it important to get sedation right?) and 4 (avoiding excessive 
sedation). 
 
“Proportion of periods with agitation” 
How was this chart made? 
The data recorded by nurses on the SQAT form at the end of each shift was used to count the number of 
periods for which agitation was present. Each data point has used 2 months of ICU admissions participating 
in the DESIST study. 
 
What does this chart mean? 
The proportion is the average rate of this quality measure that occurred in the ICU during the intervention 
period October to November 2014 in the DESIST study. This means that for 7% of care periods in the ICU 
agitation was present using the DESIST definition. 
The observed proportion is the rate of agitation over 2 months of observations in the ICU. If the proportion 
moves closer to the upper warning or control limit, the occurrence of agitation is increasing. If it crosses the 
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upper control limit this represents a significant increase in agitation in your ICU. If the proportion moves 
closer to the lower warning or control limit, the occurrence of agitation is decreasing. If it crosses the lower 
control limit this represents a significant decrease in agitation in your ICU. 
This chart suggests there has been DECREASE in agitation during the period October to November 2014. 
Agitation has several causes, including pain, poor ventilator synchronisation, delirium, anxiety, drug 
withdrawal syndromes, or other causes of discomfort such as bowel discomfort (eg. 
constipation/distension). 
To learn more about managing agitation, access the DESIST LearnPro education package, modules 6 
(managing agitation), 7 (managing delirium), and 8 (drug withdrawal). 
 
“Proportion of periods during which patient poorly relaxed” 
How was this chart made? 
The data recorded by nurses on the SQAT form at the end of each shift was used to count the number of 
periods for which patients were poorly relaxed based on ease of movement. Each data point has used 2 
months of ICU admissions participating in the DESIST study. 
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What does this chart mean? 
Poor relaxation is probably the best way of assessing pain and discomfort in patients unable to communicate 
verbally during critical illness. 
The proportion is the average rate of this quality measure that occurred in the ICU during the intervention 
period October to November 2014 in the DESIST study. This means that for 12% of care periods in the ICU 
poor relaxation was present using the DESIST definition. 
The observed proportion is the rate of poor relaxation over 2 months of observations in the ICU. If the 
proportion moves closer to the upper warning or control limit, the occurrence of poor relaxation is 
increasing. If it crosses the upper control limit this represents a significant increase in poor relaxation in your 
ICU. If the proportion moves closer to the lower warning or control limit, the occurrence of poor relaxation 
is decreasing. If it crosses the lower control limit this represents a significant decrease in poor relaxation in 
your ICU. 
This chart suggests that there has been DECREASE in poor relaxation (pain/discomfort) during the period 
October to November 2014. 
To learn more about managing pain access the DESIST LearnPro education package, module 5 (assessing 
pain and discomfort in ICU). 
 
“Proportion of periods with poor ventilator synchronisation” 
How was this chart made? 
The data recorded by nurses on the SQAT form at the end of each shift was used to count the number of 
periods for which patients had poor ventilator synchronisation (coughing or gagging frequently or unable to 
control ventilation despite adjustments). Each data point has used 2 months of ICU admissions participating 
in the DESIST study. 
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What does this chart mean? 
The proportion is the average rate of this quality measure that occurred in the the ICU during the 
intervention period October to November 2014 in the DESIST study. This means that for 5% of care periods 
in the ICU poor ventilator synchronisation was present using the DESIST definition. 
The observed proportion is the rate of poor ventilator synchronisation over 2 months of observations in the 
the ICU. If the proportion moves closer to the upper warning or control limit, the occurrence of poor 
ventilator synchronisation is increasing. If it crosses the upper control limit this represents a significant 
increase in poor ventilator synchronisation in your ICU. If the proportion moves closer to the lower warning 
or control limit, the occurrence of poor ventilator synchronisation is decreasing. If it crosses the lower 
control limit this represents a significant decrease in poor ventilator synchronisation in your ICU. 
This chart suggests there has been DECREASE in poor ventilator synchronisation during the period October 
to November 2014. 
Poor ventilator synchronisation is a common cause of agitation. To learn more access the DESIST LearnPro 
education package module 6 (managing agitation). 
 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
18/10/2012 - 
30/11/2012 
01/12/2012 - 
31/01/2013 
01/02/2013 - 
31/03/2013 
01/04/2013 - 
31/05/2013 
01/06/2013 - 
31/07/2013 
01/08/2013 - 
30/09/2013 
01/10/2013 - 
30/11/2013 
01/12/2013 - 
31/01/2014 
01/02/2014 - 
31/03/2014 
01/04/2014 - 
31/05/2014 
01/06/2014 - 
31/07/2014 
01/08/2014 - 
30/09/2014 
01/10/2014 - 
30/11/2014 
%
 o
f 
S
Q
A
T
 p
er
io
d
s 
Time period 
Poor ventilator synchronisation was present for 5% of 
care periods 
Observed 
Proportion 
Upper Control 
Limit 
Upper Warning 
Limit 
Baseline 
Proportion 
Lower Warning 
Limit 
Lower Control 
Limit 
Start of Transition 
Period 
End of Transition 
Period 
28 
 
“Proportion of periods with optimum sedation” 
How was this chart made? 
The data recorded by nurses on the SQAT form at the end of each shift was used to generate a measure of 
overall optimum sedation.  
Optimum sedation is defined as a care period (12 hour nursing shift) for which there was no excessive 
sedation or agitation or poorly relaxed patient or poor ventilator synchronisation. These patients should be 
awake or rousable, non-agitated, and comfortable on the ventilator, unless there is a clinical reason for 
keeping them deeply sedated.  
 
 
What does this chart mean? 
The proportion is the average rate of this quality measure that occurred in the the ICU during the 
intervention period October to November 2014 in the DESIST study. This means that for 62% of care periods 
in the ICU optimum sedation was present, using the DESIST definition. 
The observed proportion is the rate of optimum sedation over 2 months of observations in the the ICU. If 
the proportion moves closer to the upper warning or control limit, the occurrence of optimum sedation is 
increasing. If it crosses the upper control limit this represents a significant increase in optimum sedation in 
your ICU. If the proportion moves closer to the lower warning or control limit, the occurrence of optimum 
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sedation is decreasing. If it crosses the lower control limit this represents a significant decrease in optimum 
sedation in your ICU. 
This chart suggests there has been INCREASE in optimum sedation during the period October to November 
2014. This is largely due to DECREASE in agitation rate. 
To learn more about the importance of optimum sedation access the DESIST LearnPro education package 
module 1 (Why is it important to get sedation right?). 
 
“Number of patients treated without a sedation-related adverse event” 
How was this chart made? 
In the DESIST study data concerning sedation-related adverse events are collected and recorded on a daily 
basis. For all sequential patients admitted to your ICU and enrolled in the DESIST study these daily data have 
been used to create this chart. If an adverse event was recorded during an admission this patient was 
counted as a patient with a “sedation-related adverse event”. We have counted all the sequential patients 
enrolled in the DESIST study in your ICU between each patient in whom a sedation-related adverse event 
was recorded. The number of patients is recorded on the Y-axis, and the actual dates on which patients 
admitted experienced an adverse event on the X-axis.  
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What does this chart mean? 
If the rate of sedation-related adverse events is decreasing, there should be more “higher spikes” in the 
chart, because this means more patients were treated without an adverse event occurring. 
The average is the average rate of this quality measure that occurred in the the ICU during the intervention 
period October to November 2014 in the DESIST study. On average, a sedation-related adverse event 
occurred for every 3rd patient during that period.  
If the data points move closer to the upper control or warning limit, the rate of sedation-related adverse 
events is decreasing. If it crosses the upper control limit this represents a significant decrease compared to 
the baseline data, which probably means the rate of sedation-related adverse events has significantly 
decreased in your ICU. 
 
Sedation-related adverse events 
The number of several pre-defined sedation-related adverse events was recorded on a daily basis for 
patients participating in the DESIST study. An awareness of the events occurring in your ICU may allow you 
to plan changes and interventions to reduce adverse event rates. For example, you may review these in real 
time at local quality improvement or “M&M meetings” to explore why they are occurring. For the period 
October to November 2014, there were 4 sedation-related adverse events in the ICU.  
Total adverse events occurring during last two months period (October-November 2014) 
Type of Sedation-Related Adverse Events Number 
Unplanned NG removal 2 
Unplanned line removal (central) 1 
Unplanned extubation 1 
Total 4 
 
 
 
 
